Cetera Investment Advisers’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Cetera Investment Advisers’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,487	Closed	-$460K	–	4233
2025 Q1	$460K	Sell	3,487 -972	-22%	-$121K	﹤0.01%	2915
2024 Q4	$372K	Buy	4,459 +1,175	+36%	+$96.6K	﹤0.01%	2931
2024 Q3	$240K	Buy	3,284 +320	+11%	+$24.1K	﹤0.01%	3252
2024 Q2	$203K	Buy	2,964 +29	+1%	+$2.01K	﹤0.01%	3353
2024 Q1	$203K	Buy	+2,935	New	+$202K	﹤0.01%	3342

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cetera Investment Advisers's ITCI Position: Q2 2025 in Review

Cetera Investment Advisers sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 3,487 shares — an estimated $460K sold.

Cetera Investment Advisers first reported a position in ITCI in Q1 2024 and held it in 5 quarters. The position peaked at $460K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Cetera Investment Advisers reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Cetera Investment Advisers sold 3,487 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $460K.
Cetera Investment Advisers first reported a position in Intra-Cellular Therapies Inc. in Q1 2024 and held it in 5 quarters.
Cetera Investment Advisers's Intra-Cellular Therapies Inc. position peaked at $460K in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Cetera Investment Advisers's 13F filing for Q2 2025, filed 8 Aug 2025.